{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:36:43Z","timestamp":1788262603673,"version":"build-2803163510"},"reference-count":38,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000351","name":"British Lung Foundation","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100000351","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome","doi-asserted-by":"publisher","award":["204801\/Z\/16\/Z"],"award-info":[{"award-number":["204801\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome","doi-asserted-by":"publisher","award":["WT202849\/Z\/16\/Z"],"award-info":[{"award-number":["WT202849\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Biomedical Research Centre","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023699","name":"Health Data Research - UK","doi-asserted-by":"crossref","award":["MC_PC_19004"],"award-info":[{"award-number":["MC_PC_19004"]}],"id":[{"id":"10.13039\/501100023699","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["AA\/18\/3\/34220"],"award-info":[{"award-number":["AA\/18\/3\/34220"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N011317\/1"],"award-info":[{"award-number":["MR\/N011317\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/P00167X\/1"],"award-info":[{"award-number":["MR\/P00167X\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2022,3,9]]},"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Eosinophils are associated with airway inflammation in respiratory disease. Eosinophil production and survival is controlled partly by interleukin-5: anti-interleukin-5 agents reduce asthma and response correlates with baseline eosinophil counts. However, whether raised eosinophils are causally related to chronic obstructive pulmonary disease (COPD) and other respiratory phenotypes is not well understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We investigated causality between eosinophils and: lung function, acute exacerbations of COPD, asthma-COPD overlap (ACO), moderate-to-severe asthma and respiratory infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed Mendelian randomisation (MR) using 151 variants from genome-wide association studies of blood eosinophils in UK Biobank\/INTERVAL, and respiratory traits in UK Biobank\/SpiroMeta, using methods relying on different assumptions for validity. We performed multivariable analyses using eight cell types where there was possible evidence of causation by eosinophils.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and main results<\/jats:title>\n                    <jats:p>\n                      Causal estimates derived from individual variants were highly heterogeneous, which may arise from pleiotropy. The average effect of raising eosinophils was to increase risk of ACO (weighted median OR per SD eosinophils, 1.44 (95%CI 1.19 to 1.74)), and moderate-severe asthma (weighted median OR 1.50 (95%CI 1.23 to 1.83)), and to reduce forced expiratory volume in 1 s (FEV\n                      <jats:sub>1<\/jats:sub>\n                      )\/forced vital capacity (FVC) and FEV\n                      <jats:sub>1<\/jats:sub>\n                      (weighted median estimator, SD FEV\n                      <jats:sub>1<\/jats:sub>\n                      \/FVC: \u22120.054 (95% CI \u22120.078 to \u22120.029), effect only prominent in individuals with asthma).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Broad consistency across MR methods may suggest causation by eosinophils (although of uncertain magnitude), yet heterogeneity necessitates caution: other important mechanisms may be responsible for the impairment of respiratory health by these eosinophil-raising variants. These results could suggest that anti-IL5 agents (designed to lower eosinophils) may be valuable in treating other respiratory conditions, including people with overlapping features of asthma and COPD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/thoraxjnl-2021-217993","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T12:59:11Z","timestamp":1653310751000},"page":"496-503","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":18,"title":["Mendelian randomisation of eosinophils and other cell types in relation to lung function and disease"],"prefix":"10.1136","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1860-6337","authenticated-orcid":false,"given":"Anna","family":"Guyatt","sequence":"first","affiliation":[{"name":"Department of Health Sciences, University of Leicester, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6057-2073","authenticated-orcid":false,"given":"Catherine","family":"John","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Leicester, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander T","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Leicester, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3641-4371","authenticated-orcid":false,"given":"Nick","family":"Shrine","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Leicester, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola F","family":"Reeve","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Leicester, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"SpiroMeta consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Sayers","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, University of Nottingham, Nottingham, UK"},{"name":"NIHR Nottingham Biomedical Research Centre, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9933-3216","authenticated-orcid":false,"given":"Ian","family":"Hall","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, University of Nottingham, Nottingham, UK"},{"name":"NIHR Nottingham Biomedical Research Centre, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise V","family":"Wain","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Leicester, Leicester, UK"},{"name":"NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuala","family":"Sheehan","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Leicester, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Dudbridge","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Leicester, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin D","family":"Tobin","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Leicester, Leicester, UK"},{"name":"NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,5,10]]},"reference":[{"key":"2025073109050655000_78.5.496.1","doi-asserted-by":"publisher","DOI":"10.1177\/2040622315609251"},{"key":"2025073109050655000_78.5.496.2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S2213-2600(16)30031-5","article-title":"Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies","volume":"4","author":"Ortega","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2025073109050655000_78.5.496.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708208"},{"key":"2025073109050655000_78.5.496.4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1586\/ers.12.81","article-title":"Eosinophils as diagnostic tools in chronic lung disease","volume":"7","author":"Eltboli","year":"2013","journal-title":"Expert Rev Respir Med"},{"key":"2025073109050655000_78.5.496.5","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.150.6.7952628"},{"key":"2025073109050655000_78.5.496.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60988-X"},{"key":"2025073109050655000_78.5.496.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808991"},{"key":"2025073109050655000_78.5.496.8","unstructured":"National Institute for Health and Care Excellence . Mepolizumab for treating severe refractory eosinophilic asthma. Technology appraisal guidance [TA431], 2017. Available: https:\/\/www.nice.org.uk\/guidance\/ta431"},{"key":"2025073109050655000_78.5.496.9","unstructured":"U.S. Food and Drug Administration (FDA) . Drug trials snapshots: NUCALA, 2016. Available: https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/drug-trials-snapshots-nucala [Accessed 27 Jun 2019]."},{"key":"2025073109050655000_78.5.496.10","unstructured":"U.S. Food and Drug Administration (FDA) . Drug trials snapshots: FASENRA, 2017. Available: https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/drug-trials-snapshots-fasenra [Accessed 27 Jun 2019]."},{"key":"2025073109050655000_78.5.496.11","unstructured":"European medicines Agency . Nucala (mepolizumab), 2019. Available: https:\/\/www.ema.europa.eu\/en\/documents\/overview\/nucala-epar-medicine-overview_en.pdf [Accessed 06 Jan 2020]."},{"key":"2025073109050655000_78.5.496.12","unstructured":"European medicines Agency . Fasenra (benralizumab), 2019. Available: https:\/\/www.ema.europa.eu\/en\/documents\/overview\/fasenra-epar-medicine-overview_en.pdf [Accessed 06 Jan 2020]."},{"key":"2025073109050655000_78.5.496.13","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.cell.2016.10.042","article-title":"The allelic landscape of human blood cell trait variation and links to common complex disease","volume":"167","author":"Astle","year":"2016","journal-title":"Cell"},{"key":"2025073109050655000_78.5.496.14","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02536-2017"},{"key":"2025073109050655000_78.5.496.15","doi-asserted-by":"publisher","DOI":"10.1017\/thg.2018.6"},{"key":"2025073109050655000_78.5.496.16","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2021.1948603"},{"key":"2025073109050655000_78.5.496.17","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0342-2"},{"key":"2025073109050655000_78.5.496.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0321-7"},{"key":"2025073109050655000_78.5.496.19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k601"},{"key":"2025073109050655000_78.5.496.20","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddu328"},{"key":"2025073109050655000_78.5.496.21","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21998"},{"key":"2025073109050655000_78.5.496.22","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-019-02027-3"},{"key":"2025073109050655000_78.5.496.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0579-z"},{"key":"2025073109050655000_78.5.496.24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2213-2600(18)30389-8","article-title":"Moderate-to-severe asthma in individuals of European ancestry: a genome-wide association study","volume":"7","author":"Shrine","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2025073109050655000_78.5.496.25","unstructured":"John C , Guyatt AL , Shrine N . Genetic associations and architecture of asthma-chronic obstructive pulmonary disease overlap. medRxiv 2020;2.doi:10.1101\/2020.11.26.20236760v1"},{"key":"2025073109050655000_78.5.496.26","doi-asserted-by":"crossref","unstructured":"Williams A , Shrine N , Naghra-van Gijzel H . Genome-wide association study of susceptibility to hospitalised respiratory infections [version 1; peer review: awaiting peer review]. Wellcome Open Research 2021;6 https:\/\/wellcomeopenresearch.org\/articles\/6-290 doi:10.12688\/wellcomeopenres.17230.1","DOI":"10.12688\/wellcomeopenres.17230.1"},{"key":"2025073109050655000_78.5.496.27","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv080"},{"key":"2025073109050655000_78.5.496.28","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21965"},{"key":"2025073109050655000_78.5.496.29","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0099-7"},{"key":"2025073109050655000_78.5.496.30","doi-asserted-by":"publisher","DOI":"10.1002\/sim.9133"},{"key":"2025073109050655000_78.5.496.31","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408"},{"key":"2025073109050655000_78.5.496.32","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwv017"},{"key":"2025073109050655000_78.5.496.33","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwu283"},{"key":"2025073109050655000_78.5.496.34","unstructured":"Global Initiative for Chronic Obstructive Lung Disease I . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2020 report), 2020. Available: https:\/\/goldcopd.org\/wp-content\/uploads\/2019\/12\/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf"},{"key":"2025073109050655000_78.5.496.35","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00651-2019","article-title":"Airway inflammation in COPD: progress to precision medicine","volume":"54","author":"Brightling","year":"2019","journal-title":"Eur Respir J"},{"key":"2025073109050655000_78.5.496.36","doi-asserted-by":"publisher","DOI":"10.1038\/ng.941"},{"key":"2025073109050655000_78.5.496.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.08.008"},{"key":"2025073109050655000_78.5.496.38","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyx206"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thoraxjnl-2021-217993","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T16:05:41Z","timestamp":1753977941000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thoraxjnl-2021-217993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,10]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,4,13]]},"published-print":{"date-parts":[[2023,5]]}},"alternative-id":["10.1136\/thoraxjnl-2021-217993"],"URL":"https:\/\/doi.org\/10.1136\/thoraxjnl-2021-217993","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.07.09.20148726","asserted-by":"object"}]},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,10]]}}}